메뉴 건너뛰기




Volumn 26, Issue 6, 2003, Pages 581-587

Drug resistance in human melanoma: Mechanisms and therapeutic opportunities

Author keywords

Apoptosis; Drug resistance; Melanoma

Indexed keywords

CISPLATIN; CYCLOSPORIN A; DACARBAZINE; FOTEMUSTINE; VERAPAMIL;

EID: 0346727156     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074156     Document Type: Review
Times cited : (28)

References (78)
  • 1
    • 0033774195 scopus 로고    scopus 로고
    • Adjuvant therapy in melanoma
    • Whittaker S: Adjuvant therapy in melanoma. Clin Exp Dermatol 2000;25:497-502.
    • (2000) Clin Exp Dermatol , vol.25 , pp. 497-502
    • Whittaker, S.1
  • 2
    • 0031806982 scopus 로고    scopus 로고
    • Chemoresistance of human malignant melanoma: Cellular and molecular aspects
    • Berger W, Elbling L, Micksche M: Chemoresistance of human malignant melanoma: Cellular and molecular aspects. Onkologie 1998;21:105-110.
    • (1998) Onkologie , vol.21 , pp. 105-110
    • Berger, W.1    Elbling, L.2    Micksche, M.3
  • 4
    • 0033910314 scopus 로고    scopus 로고
    • Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease
    • Walsh P, Gibbs P, Gonzalez R: Newer strategies for effective evaluation of primary melanoma and treatment of stage III and IV disease. J Am Acad Dermatol 2000;42:480-489.
    • (2000) J Am Acad Dermatol , vol.42 , pp. 480-489
    • Walsh, P.1    Gibbs, P.2    Gonzalez, R.3
  • 6
    • 0027218689 scopus 로고
    • Biochemistry of multidrug resistance mediated by the multidrug transporter
    • Gottesman MM, Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 1993;62:385-427.
    • (1993) Annu Rev Biochem , vol.62 , pp. 385-427
    • Gottesman, M.M.1    Pastan, I.2
  • 7
    • 0031043119 scopus 로고    scopus 로고
    • The role of multidrug resistance-associated protein (MRP) expression in multidrug resistance
    • Kavallaris M: The role of multidrug resistance-associated protein (MRP) expression in multidrug resistance. Anticancer Drugs 1997;8:17-25.
    • (1997) Anticancer Drugs , vol.8 , pp. 17-25
    • Kavallaris, M.1
  • 8
    • 0035253361 scopus 로고    scopus 로고
    • Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: A Southwest Oncology Group Study
    • Gaynor ER, Unger JM, Miller TP, Grogan TM, White LA Jr., Mills GM, Balcerzak SP, Varterasian M, LeBlanc M, Fisher RI: Infusional CHOP chemotherapy (CVAD) with or without chemosensitizers offers no advantage over standard CHOP therapy in the treatment of lymphoma: A Southwest Oncology Group Study. J Clin Oncol 2001;19:750-755.
    • (2001) J Clin Oncol , vol.19 , pp. 750-755
    • Gaynor, E.R.1    Unger, J.M.2    Miller, T.P.3    Grogan, T.M.4    White Jr., L.A.5    Mills, G.M.6    Balcerzak, S.P.7    Varterasian, M.8    LeBlanc, M.9    Fisher, R.I.10
  • 10
    • 0028965334 scopus 로고
    • P-glycoprotein expression in primary and metastatic malignant melanoma
    • Schadendorf D, Herfordt R, Czarnetzki BM: P-glycoprotein expression in primary and metastatic malignant melanoma. Br J Dermatol 1995;132:551-555.
    • (1995) Br J Dermatol , vol.132 , pp. 551-555
    • Schadendorf, D.1    Herfordt, R.2    Czarnetzki, B.M.3
  • 11
    • 0344927562 scopus 로고    scopus 로고
    • Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance
    • Konig J, Nies AT, Cui Y, Leier I, Keppler D: Conjugate export pumps of the multidrug resistance protein (MRP) family: Localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1999;1461:377-394.
    • (1999) Biochim Biophys Acta , vol.1461 , pp. 377-394
    • Konig, J.1    Nies, A.T.2    Cui, Y.3    Leier, I.4    Keppler, D.5
  • 13
    • 0030932462 scopus 로고    scopus 로고
    • Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells
    • Berger W, Hauptmann E, Elbling L, Vetterlein M, Kokoschka EM, Micksche M: Possible role of the multidrug resistance-associated protein (MRP) in chemoresistance of human melanoma cells. Int J Cancer 1997;71:108-115.
    • (1997) Int J Cancer , vol.71 , pp. 108-115
    • Berger, W.1    Hauptmann, E.2    Elbling, L.3    Vetterlein, M.4    Kokoschka, E.M.5    Micksche, M.6
  • 14
    • 0035030272 scopus 로고    scopus 로고
    • Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells
    • Ichihashi N, Kitajima Y: Chemotherapy induces or increases expression of multidrug resistance-associated protein in malignant melanoma cells. Br J Dermatol 2001;144:745-750.
    • (2001) Br J Dermatol , vol.144 , pp. 745-750
    • Ichihashi, N.1    Kitajima, Y.2
  • 15
    • 0041342087 scopus 로고    scopus 로고
    • Overexpression of cMOAT (MRP2/ABC2) is associated with decreased formation of platinium-DNA adducts, decreased G2-arrest, and decreased apoptotic activities in melanoma cells resistant to cisplatin
    • Materna V, Liedert B, Schadendorf D, Lage H: Overexpression of cMOAT (MRP2/ABC2) is associated with decreased formation of platinium-DNA adducts, decreased G2-arrest, and decreased apoptotic activities in melanoma cells resistant to cisplatin. J Invest Dermatol 2003;121:172-176.
    • (2003) J Invest Dermatol , vol.121 , pp. 172-176
    • Materna, V.1    Liedert, B.2    Schadendorf, D.3    Lage, H.4
  • 16
    • 0031939392 scopus 로고    scopus 로고
    • Glutathione-related mechanisms in cellular resistance to anticancer drugs
    • Zhang K, Mack P, Wong KP: Glutathione-related mechanisms in cellular resistance to anticancer drugs. Int J Oncol 1998;12:871-882.
    • (1998) Int J Oncol , vol.12 , pp. 871-882
    • Zhang, K.1    Mack, P.2    Wong, K.P.3
  • 18
    • 0029102925 scopus 로고
    • Glutathione and related enzymes in tumor progression and metastases of human melanoma
    • Schadendorf D, Jurgovsky K, Kohlmus CM, Czarnetzki BM: Glutathione and related enzymes in tumor progression and metastases of human melanoma. J Invest Dermatol 1995;105:109-112.
    • (1995) J Invest Dermatol , vol.105 , pp. 109-112
    • Schadendorf, D.1    Jurgovsky, K.2    Kohlmus, C.M.3    Czarnetzki, B.M.4
  • 20
    • 0029553541 scopus 로고
    • Acquisition of multiple copies of a mutant topoisomerase II alpha allele by chromosome 17 aneuploidy is associated with etoposide resistance in human melanoma cell lines
    • Campain JA, Slovak ML, Schoenlein PV, Popescu NC, Gottesman MM, Pastan I: Acquisition of multiple copies of a mutant topoisomerase II alpha allele by chromosome 17 aneuploidy is associated with etoposide resistance in human melanoma cell lines. Somat Cell Mol Genet 1995;21:451-471.
    • (1995) Somat Cell Mol Genet , vol.21 , pp. 451-471
    • Campain, J.A.1    Slovak, M.L.2    Schoenlein, P.V.3    Popescu, N.C.4    Gottesman, M.M.5    Pastan, I.6
  • 21
    • 0033957570 scopus 로고    scopus 로고
    • Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance
    • Lage H, Helmbach H, Dietel M, Schadendorf D: Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance. Br J Cancer 2000;82:488-491.
    • (2000) Br J Cancer , vol.82 , pp. 488-491
    • Lage, H.1    Helmbach, H.2    Dietel, M.3    Schadendorf, D.4
  • 23
    • 0032922717 scopus 로고    scopus 로고
    • Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance
    • Lage H, Christmann M, Kern MA, Dietel M, Pick M, Kaina B, Schadendorf D: Expression of DNA repair proteins hMSH2, hMSH6, hMLH1, O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance. Int J Cancer 1999;80:744-750.
    • (1999) Int J Cancer , vol.80 , pp. 744-750
    • Lage, H.1    Christmann, M.2    Kern, M.A.3    Dietel, M.4    Pick, M.5    Kaina, B.6    Schadendorf, D.7
  • 24
    • 0034075593 scopus 로고    scopus 로고
    • Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide
    • Ruenger TM, Emmert S, Schadendorf D, Diem C, Epe B, Hellfritsch D: Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide. J Invest Dermatol 2000;114:34-39.
    • (2000) J Invest Dermatol , vol.114 , pp. 34-39
    • Ruenger, T.M.1    Emmert, S.2    Schadendorf, D.3    Diem, C.4    Epe, B.5    Hellfritsch, D.6
  • 25
    • 0035313980 scopus 로고    scopus 로고
    • Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene MGMT
    • Christmann M, Pick M, Lage H, Schadendorf D, Kaina B: Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene MGMT. Int J Cancer 2001;92:123-129.
    • (2001) Int J Cancer , vol.92 , pp. 123-129
    • Christmann, M.1    Pick, M.2    Lage, H.3    Schadendorf, D.4    Kaina, B.5
  • 28
    • 0036726694 scopus 로고    scopus 로고
    • Immunohistochemical analysis of DNA mismatch repair protein and O6-methylguanine-DNA methyltransferase in melanoma metastases in relation to clinical response to DTIC-based chemotherapy
    • Ma S, Egyhazi S, Ringborg U, Hansson J: Immunohistochemical analysis of DNA mismatch repair protein and O6-methylguanine-DNA methyltransferase in melanoma metastases in relation to clinical response to DTIC-based chemotherapy. Oncol Rep 2002;9:1015-1019.
    • (2002) Oncol Rep , vol.9 , pp. 1015-1019
    • Ma, S.1    Egyhazi, S.2    Ringborg, U.3    Hansson, J.4
  • 29
    • 0034630167 scopus 로고    scopus 로고
    • Induction of apoptosis by cancer chemotherapy
    • Kaufmann SH, Earnshaw WC: Induction of apoptosis by cancer chemotherapy. Exp Cell Res 2000; 256:42-49.
    • (2000) Exp Cell Res , vol.256 , pp. 42-49
    • Kaufmann, S.H.1    Earnshaw, W.C.2
  • 30
    • 0028960205 scopus 로고
    • Tumor type is a determinant of susceptibility to apoptosis
    • Staunton MJ, Gaffney EF: Tumor type is a determinant of susceptibility to apoptosis. Am J Clin Pathol 1995;103:300-307.
    • (1995) Am J Clin Pathol , vol.103 , pp. 300-307
    • Staunton, M.J.1    Gaffney, E.F.2
  • 32
    • 0030745646 scopus 로고    scopus 로고
    • Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3
    • Zou H, Henzel WJ, Liu X, Lutschg A, Wang X: Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997;90:405-413.
    • (1997) Cell , vol.90 , pp. 405-413
    • Zou, H.1    Henzel, W.J.2    Liu, X.3    Lutschg, A.4    Wang, X.5
  • 33
    • 0030715323 scopus 로고    scopus 로고
    • Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
    • Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479-489.
    • (1997) Cell , vol.91 , pp. 479-489
    • Li, P.1    Nijhawan, D.2    Budihardjo, I.3    Srinivasula, S.M.4    Ahmad, M.5    Alnemri, E.S.6    Wang, X.7
  • 34
    • 0033596980 scopus 로고    scopus 로고
    • An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9
    • Zou H, Li Y, Liu X, Wang X: An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999;274:11549-11556.
    • (1999) J Biol Chem , vol.274 , pp. 11549-11556
    • Zou, H.1    Li, Y.2    Liu, X.3    Wang, X.4
  • 35
    • 0030916417 scopus 로고    scopus 로고
    • DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
    • Liu X, Zou H, Slaughter C, Wang X: DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997;89:175-184.
    • (1997) Cell , vol.89 , pp. 175-184
    • Liu, X.1    Zou, H.2    Slaughter, C.3    Wang, X.4
  • 36
    • 0032078217 scopus 로고    scopus 로고
    • Caspases: Key mediators of apoptosis
    • Thornberry NA: Caspases: Key mediators of apoptosis. Chem Biol 1998;5:R97-R103.
    • (1998) Chem Biol , vol.5
    • Thornberry, N.A.1
  • 37
    • 0036275357 scopus 로고    scopus 로고
    • Drug-resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency
    • Helmbach H, Kern MA, Rossmann E, Renz K, Kissel C, Gschwendt B, Schadendorf D: Drug-resistance towards etoposide and cisplatin in human melanoma cells is associated with drug-dependent apoptosis deficiency. J Invest Dermatol 2002;118:923-932.
    • (2002) J Invest Dermatol , vol.118 , pp. 923-932
    • Helmbach, H.1    Kern, M.A.2    Rossmann, E.3    Renz, K.4    Kissel, C.5    Gschwendt, B.6    Schadendorf, D.7
  • 39
    • 0031812996 scopus 로고    scopus 로고
    • Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer
    • Miyake H, Hara I, Gohji K, Yamanaka K, Arakawa S, Kamidono S: Enhancement of chemosensitivity in human bladder cancer cells by adenoviral-mediated p53 gene transfer. Anticancer Res 1998;18:3087-3092.
    • (1998) Anticancer Res , vol.18 , pp. 3087-3092
    • Miyake, H.1    Hara, I.2    Gohji, K.3    Yamanaka, K.4    Arakawa, S.5    Kamidono, S.6
  • 41
    • 0034125805 scopus 로고    scopus 로고
    • p53-dependent apoptosis in melanoma cells after treatment with camptothecin
    • Li G, Bush JA, Ho VC: p53-dependent apoptosis in melanoma cells after treatment with camptothecin. J Invest Dermatol 2000;114:514-519.
    • (2000) J Invest Dermatol , vol.114 , pp. 514-519
    • Li, G.1    Bush, J.A.2    Ho, V.C.3
  • 42
    • 0032944017 scopus 로고    scopus 로고
    • The chemoresistance of human malignant melanoma: An update
    • Serrone L, Hersey P: The chemoresistance of human malignant melanoma: An update. Melanoma Res 1999;9:51-58.
    • (1999) Melanoma Res , vol.9 , pp. 51-58
    • Serrone, L.1    Hersey, P.2
  • 45
    • 0031059608 scopus 로고    scopus 로고
    • Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis
    • Jansen B, Schlagbauer Wadl H, Eichler HG, Wolff K, van Elsas A, Schrier PI, Pehamberger H: Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis. Cancer Res 1997;57:362-365.
    • (1997) Cancer Res , vol.57 , pp. 362-365
    • Jansen, B.1    Schlagbauer Wadl, H.2    Eichler, H.G.3    Wolff, K.4    Van Elsas, A.5    Schrier, P.I.6    Pehamberger, H.7
  • 46
    • 0036533441 scopus 로고    scopus 로고
    • Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effects
    • Smalley KS, Eisen TG: Farnesyl thiosalicylic acid inhibits the growth of melanoma cells through a combination of cytostatic and pro-apoptotic effects. Int J Cancer 2002;98:514-522.
    • (2002) Int J Cancer , vol.98 , pp. 514-522
    • Smalley, K.S.1    Eisen, T.G.2
  • 49
    • 0033609672 scopus 로고    scopus 로고
    • Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma
    • Ugurel S, Seiter S, Rappl G, Stark A, Tilgen W, Reinhold U: Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma. Int J Cancer 1999;82:727-736.
    • (1999) Int J Cancer , vol.82 , pp. 727-736
    • Ugurel, S.1    Seiter, S.2    Rappl, G.3    Stark, A.4    Tilgen, W.5    Reinhold, U.6
  • 50
    • 0033778257 scopus 로고    scopus 로고
    • Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma
    • Mouawad R, Khayat D, Soubrane C: Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in advanced melanoma. Melanoma Res 2000;10:461-467.
    • (2000) Melanoma Res , vol.10 , pp. 461-467
    • Mouawad, R.1    Khayat, D.2    Soubrane, C.3
  • 51
    • 0032530612 scopus 로고    scopus 로고
    • Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
    • Griffith TS, Chin WA, Jackson GC, Lynch DH, Kubin MZ: Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol 1998;161:2833-2840.
    • (1998) J Immunol , vol.161 , pp. 2833-2840
    • Griffith, T.S.1    Chin, W.A.2    Jackson, G.C.3    Lynch, D.H.4    Kubin, M.Z.5
  • 52
    • 0035523826 scopus 로고    scopus 로고
    • How melanoma cells evade trail-induced apoptosis
    • Hersey P, Zhang XD: How melanoma cells evade trail-induced apoptosis. Nat Rev Cancer 2001;1:142-150.
    • (2001) Nat Rev Cancer , vol.1 , pp. 142-150
    • Hersey, P.1    Zhang, X.D.2
  • 53
    • 0034283942 scopus 로고    scopus 로고
    • Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/apo-2 ligand gene induces tumor cell apoptosis
    • Griffith TS, Anderson RD, Davidson BL, Williams RD, Ratliff TL: Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/apo-2 ligand gene induces tumor cell apoptosis. J Immunol 2000;165:2886-2894.
    • (2000) J Immunol , vol.165 , pp. 2886-2894
    • Griffith, T.S.1    Anderson, R.D.2    Davidson, B.L.3    Williams, R.D.4    Ratliff, T.L.5
  • 55
    • 0033529266 scopus 로고    scopus 로고
    • Postmitochondrial regulation of apoptosis during heart failure
    • Reed JC, Paternostro G: Postmitochondrial regulation of apoptosis during heart failure. Proc Natl Acad Sci U S A 1999;96:7614-7616.
    • (1999) Proc Natl Acad Sci U S A , vol.96 , pp. 7614-7616
    • Reed, J.C.1    Paternostro, G.2
  • 57
    • 0036719158 scopus 로고    scopus 로고
    • Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity
    • Iervolino A, Trisciuoglio D, Ribatti D, Candiloro A, Biroccio A, Zupi G, Del Bufalo D: Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity. FASEB J 2002;16:1453-1455.
    • (2002) FASEB J , vol.16 , pp. 1453-1455
    • Iervolino, A.1    Trisciuoglio, D.2    Ribatti, D.3    Candiloro, A.4    Biroccio, A.5    Zupi, G.6    Del Bufalo, D.7
  • 58
    • 0034948497 scopus 로고    scopus 로고
    • c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells
    • Biroccio A, Benassi B, Amodei S, Gabellini C, Del Bufalo D, Zupi G: c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells. Mol Pharmacol 2001;60:174-182.
    • (2001) Mol Pharmacol , vol.60 , pp. 174-182
    • Biroccio, A.1    Benassi, B.2    Amodei, S.3    Gabellini, C.4    Del Bufalo, D.5    Zupi, G.6
  • 63
    • 0033397882 scopus 로고    scopus 로고
    • Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma
    • Grossman D, McNiff JM, Li F, Altieri DC: Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma. J Invest Dermatol 1999;113:1076-1081.
    • (1999) J Invest Dermatol , vol.113 , pp. 1076-1081
    • Grossman, D.1    McNiff, J.M.2    Li, F.3    Altieri, D.C.4
  • 66
    • 0035793557 scopus 로고    scopus 로고
    • Livin, a novel inhibitor of apoptosis protein family member
    • Kasof GM, Gomes BC: Livin, a novel inhibitor of apoptosis protein family member. J Biol Chem 2001;276:3238-3246.
    • (2001) J Biol Chem , vol.276 , pp. 3238-3246
    • Kasof, G.M.1    Gomes, B.C.2
  • 67
    • 0034597630 scopus 로고    scopus 로고
    • ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
    • Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM: ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 2000;10:1359-1366.
    • (2000) Curr Biol , vol.10 , pp. 1359-1366
    • Vucic, D.1    Stennicke, H.R.2    Pisabarro, M.T.3    Salvesen, G.S.4    Dixit, V.M.5
  • 69
    • 0034680876 scopus 로고    scopus 로고
    • Molecular determinants of the caspase-promoting activity of Smac/ DIABLO and its role in the death receptor pathway
    • Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang Z, Alnemri ES: Molecular determinants of the caspase-promoting activity of Smac/ DIABLO and its role in the death receptor pathway. J Biol Chem 2000;275:36152-36157.
    • (2000) J Biol Chem , vol.275 , pp. 36152-36157
    • Srinivasula, S.M.1    Datta, P.2    Fan, X.J.3    Fernandes-Alnemri, T.4    Huang, Z.5    Alnemri, E.S.6
  • 72
    • 0033811376 scopus 로고    scopus 로고
    • Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis
    • Sinha P, Kohl S, Fischer J, Hütter G, Kern M, Köttgen E, Dietel M, Lage H, Schölzer M, Schadendorf D: Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis. Electrophoresis 2000;21:3048-3057.
    • (2000) Electrophoresis , vol.21 , pp. 3048-3057
    • Sinha, P.1    Kohl, S.2    Fischer, J.3    Hütter, G.4    Kern, M.5    Köttgen, E.6    Dietel, M.7    Lage, H.8    Schölzer, M.9    Schadendorf, D.10
  • 73
    • 0012650752 scopus 로고    scopus 로고
    • Phase I trail of 17AAG (17-allylamino 17-demethoxygeldanmycine in patients with advanced cancer
    • Scher HI, Solit DB, Munster PN: Phase I trail of 17AAG (17-allylamino 17-demethoxygeldanmycine in patients with advanced cancer. Proc AARC-NCI-EORTC Int Conf 2001:A 292.
    • (2001) Proc AARC-NCI-EORTC Int Conf
    • Scher, H.I.1    Solit, D.B.2    Munster, P.N.3
  • 74
    • 0037108860 scopus 로고    scopus 로고
    • Identification of the human PHLDA1/TDAG51 gene: Down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation
    • Neef R, Kuske MA, Prols E, Johnson JP: Identification of the human PHLDA1/TDAG51 gene: Down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation. Cancer Res 2002;62:5920-5929.
    • (2002) Cancer Res , vol.62 , pp. 5920-5929
    • Neef, R.1    Kuske, M.A.2    Prols, E.3    Johnson, J.P.4
  • 76
    • 0033762077 scopus 로고    scopus 로고
    • Identification of differentially expressed genes in human melanoma cells with aquuired resistance to various antineoplastic drugs
    • Grottke C, Mantwill K, Dietel M, Schadendorf D, Lage H: Identification of differentially expressed genes in human melanoma cells with aquuired resistance to various antineoplastic drugs. Int J Cancer 2000;88:535-546.
    • (2000) Int J Cancer , vol.88 , pp. 535-546
    • Grottke, C.1    Mantwill, K.2    Dietel, M.3    Schadendorf, D.4    Lage, H.5
  • 78
    • 0013161392 scopus 로고    scopus 로고
    • Mechanisms of ras protein targeting in Mammalian cells
    • Silvius JR: Mechanisms of ras protein targeting in Mammalian cells. J Membr Biol 2002;190:83-92.
    • (2002) J Membr Biol , vol.190 , pp. 83-92
    • Silvius, J.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.